Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers
International Journal of Molecular Sciences · 11.10.2023 · 24 (20) · 15077
DOI: 10.3390/ijms242015077 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.10.2023. Verfasst von Eros Azzalini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences (DSM), University of Trieste, 34149 Trieste, Italy. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cystadenocarcinoma, Serous. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ovarian cancers encompass a group of neoplasms originating from germinal tissues and exhibiting distinct clinical, pathological, and molecular features. Among these, epithelial ovarian cancers (EOCs) are the most prevalent, comprising five distinct tumor histotypes. Notably, high-grade serous ovarian cancers (HGSOCs) represent the majority, accounting for over 70% of EOC cases. Due to their silent and asymptomatic behavior, HGSOCs are generally diagnosed in advanced stages with an evolved and complex genomic state, characterized by high intratumor heterogeneity (ITH) due to chromosomal instability that distinguishes HGSOCs. Histologically, these cancers exhibit significant morphological diversity both within and between tumors. The histologic patterns associated with solid, endometrioid, and transitional (SET) and classic subtypes of HGSOCs offer prognostic insights and may indicate specific molecular profiles. The evolution of HGSOC from primary to metastasis is typically characterized by clonal ITH, involving shared or divergent mutations in neoplastic sub-clones within primary and metastatic sites. Disease progression and therapy resistance are also influenced by non-clonal ITH, related to interactions with the tumor microenvironment and further genomic changes. Notably, significant alterations occur in nonmalignant cells, including cancer-associated fibroblast and immune cells, during tumor progression. This review provides an overview of the complex nature of HGSOC, encompassing its various aspects of intratumor heterogeneity, histological patterns, and its dynamic evolution during progression and therapy resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences (DSM), University of Trieste, 34149 Trieste, Italy.
- Pathology Unit, Centro di Riferimento Oncologico (CRO) IRCCS, Aviano-National Cancer Institute, 33081 Pordenone, Italy.
ORCID-Profile: Eros Azzalini, Vincenzo Canzonieri, Serena Bonin
Zitieren
APA
Azzalini, E., Stanta, G., Canzonieri, V., & Bonin, S. (2023). Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers. International Journal of Molecular Sciences, 24(20), 15077. https://doi.org/10.3390/ijms242015077
Vancouver
Azzalini E, Stanta G, Canzonieri V, Bonin S. Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers. International Journal of Molecular Sciences. 2023;24(20):15077. doi:10.3390/ijms242015077
BibTeX
@article{Azzalini2023,
author = {Azzalini, Eros and Stanta, Giorgio and Canzonieri, Vincenzo and Bonin, Serena},
title = {Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {20},
pages = {15077},
doi = {10.3390/ijms242015077}
}
EUVIMED